Download PDF
Am J Perinatol 2018; 35(11): 1071-1078
DOI: 10.1055/s-0038-1639340
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Stillbirth, Inflammatory Markers, and Obesity: Results from the Stillbirth Collaborative Research Network

Margo S. Harrison
1   Columbia University Medical Center, New York, New York
,
Vanessa R. Thorsten
2   RTI International, Research Triangle Park, North Carolina
,
Donald J. Dudley
3   University of Virginia, Charlottesville, Virginia
,
Corette B. Parker
2   RTI International, Research Triangle Park, North Carolina
,
Matthew A. Koch
2   RTI International, Research Triangle Park, North Carolina
,
Carol J.R. Hogue
4   Emory University, Atlanta, Georgia
,
Barbara J. Stoll
5   University of Texas Health McGovern Medical School, Houston, Texas
,
Robert M. Silver
6   University of Utah Health Sciences Center, Salt Lake City, Utah
,
Michael W. Varner
6   University of Utah Health Sciences Center, Salt Lake City, Utah
,
M. Halit Pinar
7   Brown University, Providence, Rhode Island
,
Donald R. Coustan
7   Brown University, Providence, Rhode Island
,
George R. Saade
8   University of Texas Medical Branch, Galveston, Texas
,
Radek K. Bukowski
9   University of Texas at Austin, Austin, Texas
,
Deborah L. Conway
10   University of Texas Health Science Center at San Antonio, San Antonio, Texas
,
Marian Willinger
11   Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland
,
Uma M. Reddy
11   Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland
,
Robert L. Goldenberg
1   Columbia University Medical Center, New York, New York
› Author Affiliations Funding This work, including the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript, was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development: U10-HD045953 Brown University, Rhode Island; U10-HD045925 Emory University, Georgia; U10-HD045952 University of Texas Medical Branch at Galveston, Texas; U10-HDO45955 University of Texas Health Sciences Center at San Antonio, Texas; U10-HD045944 University of Utah Health Sciences Center, Utah; and U01-HD045954 and HHSN275201400001C RTI International, North Carolina.
Further Information

Publication History

04 December 2017

12 February 2018

Publication Date:
02 April 2018 (online)

    Permissions and Reprints

Abstract

Background Obesity is associated with increased risk of stillbirth, although the mechanisms are unknown. Obesity is also associated with inflammation. Serum ferritin, C-reactive protein, white blood cell count, and histologic chorioamnionitis are all markers of inflammation.

Objective This article determines if inflammatory markers are associated with stillbirth and body mass index (BMI). Additionally, we determined whether inflammatory markers help to explain the known relationship between obesity and stillbirth.

Study Design White blood cell count was assessed at admission to labor and delivery, maternal serum for assessment of various biomarkers was collected after study enrollment, and histologic chorioamnionitis was based on placental histology. These markers were compared for stillbirths and live births overall and within categories of BMI using analysis of variance on logarithmic-transformed markers and logistic regression for dichotomous variables. The impact of inflammatory markers on the association of BMI categories with stillbirth status was assessed using crude and adjusted odds ratios (COR and AOR, respectively) from logistic regression models. The interaction of inflammatory markers and BMI categories on stillbirth status was also assessed through logistic regression. Additional logistic regression models were used to determine if the association of maternal serum ferritin with stillbirth is different for preterm versus term births. Analyses were weighted for the overall population from which this sample was derived.

Results A total of 497 women with singleton stillbirths and 1,414 women with live births were studied with prepregnancy BMI (kg/m2) categorized as normal (18.5–24.9), overweight (25.0–29.9), or obese (30.0 + ). Overweight (COR, 1.48; 95% confidence interval [CI]: 1.14–1.94) and obese women (COR, 1.60; 95% CI: 1.23–2.08) were more likely than normal weight women to experience stillbirth. Serum ferritin levels were higher (geometric mean: 37.4 ng/mL vs. 23.3, p < 0.0001) and C-reactive protein levels lower (geometric mean: 2.9 mg/dL vs. 3.3, p = 0.0279), among women with stillbirth compared with live birth. Elevated white blood cell count (15.0 uL × 103 or greater) was associated with stillbirth (21.2% SB vs. 10.0% live birth, p < 0.0001). Histologic chorioamnionitis was more common (33.2% vs. 15.7%, p < 0.0001) among women with stillbirth compared with those with live birth. Serum ferritin, C-reactive protein, and chorioamnionitis had little impact on the ORs associating stillbirth with overweight or obesity. Adjustment for elevated white blood cell count did not meaningfully change the OR for stillbirth in overweight versus normal weight women. However, the stillbirth OR for obese versus normal BMI changed by more than 10% when adjusting for histologic chorioamnionitis (AOR, 1.38; 95% CI: 1.02–1.88), indicating confounding. BMI by inflammatory marker interaction terms were not significant. The association of serum ferritin levels with stillbirth was stronger among preterm births (p = 0.0066).

Conclusion Maternal serum ferritin levels, elevated white blood cell count, and histologic chorioamnionitis were positively and C-reactive protein levels negatively associated with stillbirth. Elevated BMIs, both overweight and obese, were associated with stillbirth when compared with women with normal BMI. None of the inflammatory markers fully accounted for the relationship between obesity and stillbirth. The association of maternal serum ferritin with stillbirth was stronger in preterm than term stillbirths.

Keywords

stillbirth - obesity - body mass index - inflammation - biomarkers

Condensation

The relationship between BMI and SB is not fully explained by the inflammatory markers studied (serum ferritin, CRP, WBC count, and chorioamnionitis).


Note

This study was presented as a poster presentation at the 37th Annual Pregnancy Meeting of Society of Maternal Fetal Medicine, January 23–28, 2017, Las Vegas, NV. Study identification number and URL of study site: https://www.nichd.nih.gov/research/supported/Pages/scrn.aspx


 

  • References

  • 1 Chu SY, Kim SY, Lau J. , et al. Maternal obesity and risk of stillbirth: a meta-analysis. Am J Obstet Gynecol 2007; 197 (03) 223-228
    CrossrefPubMedGoogle Scholar
  • 2 Maurizi G, Della Guardia L, Maurizi A, Poloni A. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol 2018; 233 (01) 88-97
    CrossrefPubMedGoogle Scholar
  • 3 Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11 (02) 85-97
    CrossrefPubMedGoogle Scholar
  • 4 McDonald SD, Han Z, Mulla S, Beyene J. ; Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010; 341: c3428
    CrossrefPubMedGoogle Scholar
  • 5 Lahra MM, Gordon A, Jeffery HE. Chorioamnionitis and fetal response in stillbirth. Am J Obstet Gynecol 2007; 196 (03) 229.e1-229.e4
    CrossrefPubMedGoogle Scholar
  • 6 Blackwell C. The role of infection and inflammation in stillbirths: parallels with SIDS?. Front Immunol 2015; 6: 248
    CrossrefPubMedGoogle Scholar
  • 7 Parker CB, Hogue CJ, Koch MA. , et al; Stillbirth Collaborative Research Network. Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatr Perinat Epidemiol 2011; 25 (05) 425-435
    CrossrefPubMedGoogle Scholar
  • 8 Bukowski R, Carpenter M, Conway D. , et al; Stillbirth Collaborative Research Network Writing Group. Association between stillbirth and risk factors known at pregnancy confirmation. JAMA 2011; 306 (22) 2469-2479
    CrossrefPubMedGoogle Scholar
  • 9 Tita ATN, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010; 37 (02) 339-354
    CrossrefPubMedGoogle Scholar
  • 10 Pinar H, Goldenberg RL, Koch MA. , et al. Placental findings in singleton stillbirths. Obstet Gynecol 2014; 123 (2 Pt 1): 325-336
    CrossrefPubMedGoogle Scholar
  • 11 Yao R, Ananth CV, Park BY, Pereira L, Plante LA. ; Perinatal Research Consortium. Obesity and the risk of stillbirth: a population-based cohort study. Am J Obstet Gynecol 2014; 210 (05) 457.e1-457.e9
    CrossrefPubMedGoogle Scholar
  • 12 Gold KJ, Mozurkewich EL, Puder KS, Treadwell MC. Maternal complications associated with stillbirth delivery: a cross-sectional analysis. J Obstet Gynaecol 2016; 36 (02) 208-212
    CrossrefPubMedGoogle Scholar
  • 13 Khan A, Khan WM, Ayub M, Humayun M, Haroon M. Ferritin is marker of inflammation rather than iron deficiency in overweight and obese people. J Obes 2016; 2016: 1937320
    PubMedGoogle Scholar
  • 14 Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282 (22) 2131-2135
    CrossrefPubMedGoogle Scholar
  • 15 Herishanu Y, Rogowski O, Polliack A, Marilus R. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 2006; 76 (06) 516-520
    CrossrefPubMedGoogle Scholar
  • 16 Kabiru W, Raynor BD. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol 2004; 191 (03) 928-932
    CrossrefPubMedGoogle Scholar
  • 17 Page JM, Christiansen-Lindquist L, Thorsten V. , et al. Diagnostic tests for evaluation of stillbirth: results from the Stillbirth Collaborative Research Network. Obstet Gynecol 2017; 129 (04) 699-706 ; epub ahead of print
    CrossrefPubMedGoogle Scholar
  • 18 Korteweg FJ, Erwich JJ, Holm JP. , et al. Diverse placental pathologies as the main causes of fetal death. Obstet Gynecol 2009; 114 (04) 809-817
    CrossrefPubMedGoogle Scholar